Table 1.
Baseline characteristics of obese patients and control participants
| Morbid obesity N = 24 |
Control N = 15 |
p value | ||
|---|---|---|---|---|
| Ages (years) | 38.4 ± 8.8 | 33.6 ± 9.3 | 0.1 | |
| Gender | Male | 6 (25%) | 5 (33.3%) | 0.7 |
| Female | 18 (75%) | 10 (66.6%) | 0.5 | |
| Weight (kg) | 132.2 ± 21.4 | 70.2 ± 10.2 | < .01 | |
| BMI (kg/m2) | 45.6 ± 5.9 | 23.4 ± 1.4 | < .01 | |
| WHR | 0.9 (0.8–1) | 0.8 (0.8–0.9) | < .01 | |
| ANG-2 (pg/ml) | 1.3 (0.5–1.5) | 0.3 (0.1–0.6) | < .05 | |
| Follistatin (pg/ml) | 0.2 (0.1–0.4) | 0.1 (0.1–0.2) | 0.05 | |
| G-CSF (pg/ml) | 0.07 (0.05–0.08) | 0.05 (0.04–0.06) | < .05 | |
| HGF (pg/ml) | 0.7 (0.3–0.8) | 0.1 (0.07–0.3) | < .01 | |
| PDGF-BB (pg/ml) | 3.5 (2–3.9) | 2.1 (1.4–3.3) | 0.06 | |
| PECAM-1 (pg/ml) | 5.5 (0.8–6.6) | 0.4 (0.3–0.9) | < .01 | |
| VEGF (pg/ml) | 0.3 (0.1–0.5) | 0.07 (0.06–0.1) | < .01 | |
Data are presented as the means ± SDs or medians (interquartile ranges) for continuous variables. Group differences were calculated using the unpaired Student’s t test or the Mann-Whitney U test for nonnormally distributed data. BMI, body mass index; WHR, waist-to-hip circumference ratio; ANG-2, angiopoietin 2; G-CSF, granulocyte colony-stimulating factor; HGF, hepatocyte growth factor; PDGF-BB, platelet-derived growth factor-BB; PECAM-1, platelet endothelial cell adhesion molecule; VEGF, vascular endothelial growth factor